Medulloblastoma

A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Also Known As:

Medulloblastoma, Adult; Medulloblastoma, Childhood; Melanocytic Medulloblastoma; Adult Medulloblastoma; Adult Medulloblastomas; Childhood Medulloblastoma; Childhood Medulloblastomas; Desmoplastic Medulloblastoma; Desmoplastic Medulloblastomas; Medulloblastoma, Melanocytic; Medulloblastomas; Medulloblastomas, Adult; Medulloblastomas, Childhood; Medulloblastomas, Desmoplastic; Medulloblastomas, Melanocytic; Medullomyoblastomas; Melanocytic Medulloblastomas; Arachnoidal Cerebellar Sarcoma, Circumscribed; Medulloblastoma, Desmoplastic; Medullomyoblastoma; Sarcoma, Cerebellar, Circumscribed Arachnoidal

Neoplasms: 1361496
- Neoplasms by Histologic Type: 2
  - Germ Cell and Embryonal Neoplasms: 4514
    - Neuroectodermal Tumors: 216
      - Neuroepithelial Neoplasms: 422
        Glioma: 43307
        Medulloblastoma: 4307
        Primitive Neuroectodermal Tumors: 1991
        Medulloblastoma: 4307
  - Glandular and Epithelial Neoplasms: 445
    - Neuroepithelial Neoplasms: 422
      - Glioma: 43307
        Medulloblastoma: 4307
      - Primitive Neuroectodermal Tumors: 1991
        Medulloblastoma: 4307
  - Nerve Tissue Neoplasms: 1
    - Neuroectodermal Tumors: 216
      - Neuroepithelial Neoplasms: 422
        Glioma: 43307
        Medulloblastoma: 4307
        Primitive Neuroectodermal Tumors: 1991
        Medulloblastoma: 4307

Philippe Bret Selected Research

Philippe Bret Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure